Your position：Home > Industry Information

Who should be prioritised for #COVID-19 vaccines?

As effective vaccines and preventive medications become available for COVID-19, demand is likely to outstrip supply, so we need to develop a strategy to prioritise their use to ensure maximum public health and societal benefits. Interim advice from the Joint Committee on Vaccination and Immunisation1 suggests that people older than 65 years of age, those in shielding groups, and health-care workers should be prioritised for vaccination. The advice lacks detail, and it is essential that a plan is developed that takes the growing body of evidence on the effect of comorbidities, occupational, and socioeconomic factors on COVID-19 severity into account...

Previous：Diosmin and Micronized Purified Flavonoid Fraction
Next：Research indicates that vitamin D3 supplementation can help repair damage to the cardiovascular system